| # | Drug | Count |
|---|---|---|
| 0 | FINGOLIMOD HCL | 8 |
| 1 | ADALIMUMAB | 7 |
| 2 | DILUENT | 5 |
| 3 | NIRSEVIMAB | 5 |
| 4 | ERGOCALCIFEROL | 3 |
| 5 | OFATUMUMAB | 3 |
| 6 | OMEPRAZOLE | 2 |
| 7 | OMEPRAZOLE MAGNESIUM | 2 |
| 8 | ACETAMINOPHEN | 1 |
| 9 | ALBUTEROL | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DILUENT | 5 | 0.0048 |
| 1 | NIRSEVIMAB | 5 | 0.0028 |
| 2 | PYRIDOSTIGMINE BROMIDE | 1 | 0.0001 |
| 3 | ERGOCALCIFEROL | 3 | 0.0001 |
| 4 | FINGOLIMOD HCL | 8 | 0.0001 |
| 5 | OFATUMUMAB | 3 | 0.0001 |
| 6 | THEOPHYLLINE ANHYDROUS | 1 | 0.0001 |
| 7 | CANDESARTAN CILEXETIL | 1 | 0.0000 |
| 8 | FULVESTRANT | 1 | 0.0000 |
| 9 | MIRABEGRON | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] | 5 | 0.0028 |
| 1 | Estrogen Receptor Antagonist [EPC] | 1 | 0.0000 |
| 2 | beta3-Adrenergic Agonist [EPC] | 1 | 0.0000 |
| 3 | Methylxanthine [EPC] | 1 | 0.0000 |
| 4 | Histamine-1 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 5 | Insulin Analog [EPC] | 5 | 0.0000 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 3 | 0.0000 |
| 7 | Phosphodiesterase 5 Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Vitamin C [EPC] | 2 | 0.0000 |
| 9 | Proton Pump Inhibitor [EPC] | 2 | 0.0000 |